- call +1-201-465-4211
- email sales@mrinsights.biz
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
Scope of the Report:
The global average price of Polio Vaccine is in the increasing trend, from 497 USD/K doses in 2012 to 534 USD/K doses in 2016. With the situation of global economy and the IPV more and more popular, prices will be in increasing trend in the following five years.
The classification of Polio Vaccine includes Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), and the revenue proportion of Inactivated Polio Vaccine (IPV) in 2016 is about 15.4%, and the proportion is in decreasing trend from 2012 to 2016.
The worldwide market for Polio Vaccine is expected to grow at a CAGR of roughly 5.0% over the next five years, will reach 1630 million US$ in 2024, from 1210 million US$ in 2019, according to a new study.
This report focuses on the Polio Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market Segment by Applications, can be divided into
Public
Private
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polio Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polio Vaccine, with price, sales, revenue and global market share of Polio Vaccine in 2017 and 2018.
Chapter 3, the Polio Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polio Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Polio Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Polio Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Inactivated Polio Vaccine (IPV)
1.2.2 Oral Polio Vaccine (OPV)
1.3 Market Analysis by Applications
1.3.1 Public
1.3.2 Private
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Polio Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Polio Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bibcol
2.3.1 Business Overview
2.3.2 Polio Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bibcol Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Serum Institute
2.4.1 Business Overview
2.4.2 Polio Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Serum Institute Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Tiantan Biological
2.5.1 Business Overview
2.5.2 Polio Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Tiantan Biological Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 IMBCA
2.6.1 Business Overview
2.6.2 Polio Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 IMBCA Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Panacea Biotec Ltd
2.7.1 Business Overview
2.7.2 Polio Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bio-Med
2.8.1 Business Overview
2.8.2 Polio Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bio-Med Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Business Overview
2.9.2 Polio Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Polio Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Polio Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Polio Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Polio Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Polio Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Polio Vaccine Market Analysis by Regions
4.1 Global Polio Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Polio Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Polio Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Polio Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Polio Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Polio Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Polio Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Polio Vaccine Sales and Growth Rate (2014-2019)
5 North America Polio Vaccine by Country
5.1 North America Polio Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Polio Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Polio Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Polio Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Polio Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Polio Vaccine Sales and Growth Rate (2014-2019)
6 Europe Polio Vaccine by Country
6.1 Europe Polio Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Polio Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Polio Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Polio Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Polio Vaccine Sales and Growth Rate (2014-2019)
6.4 France Polio Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Polio Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Polio Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Polio Vaccine by Country
7.1 Asia-Pacific Polio Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Polio Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Polio Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Polio Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Polio Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Polio Vaccine Sales and Growth Rate (2014-2019)
7.5 India Polio Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Polio Vaccine Sales and Growth Rate (2014-2019)
8 South America Polio Vaccine by Country
8.1 South America Polio Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Polio Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Polio Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Polio Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Polio Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Polio Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Polio Vaccine by Countries
9.1 Middle East and Africa Polio Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Polio Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Polio Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Polio Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Polio Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Polio Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Polio Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Polio Vaccine Sales and Growth Rate (2014-2019)
10 Global Polio Vaccine Market Segment by Type
10.1 Global Polio Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Polio Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Polio Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Inactivated Polio Vaccine (IPV) Sales Growth and Price
10.2.1 Global Inactivated Polio Vaccine (IPV) Sales Growth (2014-2019)
10.2.2 Global Inactivated Polio Vaccine (IPV) Price (2014-2019)
10.3 Oral Polio Vaccine (OPV) Sales Growth and Price
10.3.1 Global Oral Polio Vaccine (OPV) Sales Growth (2014-2019)
10.3.2 Global Oral Polio Vaccine (OPV) Price (2014-2019)
11 Global Polio Vaccine Market Segment by Application
11.1 Global Polio Vaccine Sales Market Share by Application (2014-2019)
11.2 Public Sales Growth (2014-2019)
11.3 Private Sales Growth (2014-2019)
12 Polio Vaccine Market Forecast (2019-2024)
12.1 Global Polio Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Polio Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Polio Vaccine Market Forecast (2019-2024)
12.2.2 Europe Polio Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Polio Vaccine Market Forecast (2019-2024)
12.2.4 South America Polio Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Polio Vaccine Market Forecast (2019-2024)
12.3 Polio Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Polio Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Polio Vaccine Market Share Forecast by Type (2019-2024)
12.4 Polio Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Polio Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Polio Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Polio Vaccine Picture
Table Product Specifications of Polio Vaccine
Figure Global Sales Market Share of Polio Vaccine by Types in 2018
Table Polio Vacci
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
